US 11932851
Exon skipping compositions for treating muscular dystrophy
granted A61KA61K31/713A61K47/60
Quick answer
US patent 11932851 (Exon skipping compositions for treating muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Mar 19 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/713, A61K47/60, A61K47/6455, A61P